These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 7397479)

  • 1. Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients.
    Confavreux C; Aimard G; Devic M
    Brain; 1980 Jun; 103(2):281-300. PubMed ID: 7397479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural history of multiple sclerosis: a unifying concept.
    Confavreux C; Vukusic S
    Brain; 2006 Mar; 129(Pt 3):606-16. PubMed ID: 16415308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early prognostic factors for disability in multiple sclerosis, a European multicenter study.
    Riise T; Grønning M; Fernández O; Lauer K; Midgard R; Minderhoud JM; Nyland H; Pálffy G; Poser S; Aarli JA
    Acta Neurol Scand; 1992 Mar; 85(3):212-8. PubMed ID: 1575007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history of multiple sclerosis: risk factors and prognostic indicators.
    Vukusic S; Confavreux C
    Curr Opin Neurol; 2007 Jun; 20(3):269-74. PubMed ID: 17495619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical aspects of multiple sclerosis in north-east Scotland with particular reference to its course and prognosis.
    Phadke JG
    Brain; 1990 Dec; 113 ( Pt 6)():1597-628. PubMed ID: 2276037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Late onset multiple sclerosis].
    Delalande S; De Seze J; Ferriby D; Stojkovic T; Vermersch P
    Rev Neurol (Paris); 2002 Nov; 158(11):1082-7. PubMed ID: 12451340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relapses and progression of disability in multiple sclerosis.
    Confavreux C; Vukusic S; Moreau T; Adeleine P
    N Engl J Med; 2000 Nov; 343(20):1430-8. PubMed ID: 11078767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical analysis of 70 neuropathologic cases of multiple sclerosis].
    Izquierdo G; Hauw JJ; Lyon-Caen O; Marteau R; Escourolle R; Buge A; Castaigne P; Lhermitte F
    Rev Neurol (Paris); 1985; 141(8-9):546-52. PubMed ID: 4089416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival pattern and cause of death in patients with multiple sclerosis: results from an epidemiological survey in north east Scotland.
    Phadke JG
    J Neurol Neurosurg Psychiatry; 1987 May; 50(5):523-31. PubMed ID: 3495637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age at disability milestones in multiple sclerosis.
    Confavreux C; Vukusic S
    Brain; 2006 Mar; 129(Pt 3):595-605. PubMed ID: 16415309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Course of illness and prognosis of multiple sclerosis. 1: The natural illness course].
    Flachenecker P; Hartung HP
    Nervenarzt; 1996 Jun; 67(6):435-43. PubMed ID: 8767197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution and severity markers in 233 MS patients.
    Bernardi S; Buttinelli C; Grasso MG; Millefiorini E; Pace A; Prencipe M; Fieschi C
    Riv Neurol; 1987; 57(3):197-200. PubMed ID: 3672012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex as a determinant of relapse incidence and progressive course of multiple sclerosis.
    Kalincik T; Vivek V; Jokubaitis V; Lechner-Scott J; Trojano M; Izquierdo G; Lugaresi A; Grand'maison F; Hupperts R; Oreja-Guevara C; Bergamaschi R; Iuliano G; Alroughani R; Van Pesch V; Amato MP; Slee M; Verheul F; Fernandez-Bolanos R; Fiol M; Spitaleri DL; Cristiano E; Gray O; Cabrera-Gomez JA; Shaygannejad V; Herbert J; Vucic S; Needham M; Petkovska-Boskova T; Sirbu CA; Duquette P; Girard M; Grammond P; Boz C; Giuliani G; Rio ME; Barnett M; Flechter S; Moore F; Singhal B; Bacile EA; Saladino ML; Shaw C; Skromne E; Poehlau D; Vella N; Spelman T; Liew D; Kilpatrick TJ; Butzkueven H;
    Brain; 2013 Dec; 136(Pt 12):3609-17. PubMed ID: 24142147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of relapse rate in MS clinical trials.
    Held U; Heigenhauser L; Shang C; Kappos L; Polman C;
    Neurology; 2005 Dec; 65(11):1769-73. PubMed ID: 16344520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The natural history of multiple sclerosis: a geographically based study 9: observations on the progressive phase of the disease.
    Kremenchutzky M; Rice GP; Baskerville J; Wingerchuk DM; Ebers GC
    Brain; 2006 Mar; 129(Pt 3):584-94. PubMed ID: 16401620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognosis in multiple sclerosis].
    Kesselring J
    Schweiz Med Wochenschr; 1997 Mar; 127(12):500-5. PubMed ID: 9148400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Course and prognosis of multiple sclerosis. Report of 90 cases].
    Yu M; Zhao BX
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Feb; 22(1):8-11, 61. PubMed ID: 2805983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic criteria in multiple sclerosis].
    Poser S
    Fortschr Med; 1975 Oct; 93(30):1481-3. PubMed ID: 1225806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical picture of multiple sclerosis with late onset.
    Cazzullo CL; Ghezzi A; Marforio S; Caputo D
    Acta Neurol Scand; 1978 Sep; 58(3):190-6. PubMed ID: 716837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.